Exhibit 99.1 CLEARMIND MEDICINE INC. Condensed Interim Consolidated Financial Statements For The Three and Nine Months Ended July 31, 2023 (Expressed in United States Dollars) (Unaudited) CLEARMIND MEDICINE INC. Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) (Unaudited) July 31, October 31, 2023 2022 Assets Current assets Cash and cash equivalents $3,847,259$ 128,777 Other receivables 108,255 50,933 Short-term investment (Note 3) 122,779 193,750 Prepai ...